Adjei AA - Search Results

1

Lung cancer-celebrating progress and acknowledging challenges.

Adjei AA. Adjei AA. J Thorac Oncol. 2013 Nov;8(11):1350-1. doi: 10.1097/JTO.0000000000000008. J Thorac Oncol. 2013. PMID: 24128710 Free article. No abstract available.

2

The Akt/mTOR and mitogen-activated protein kinase pathways in lung cancer therapy.

Papadimitrakopoulou V, Adjei AA. Papadimitrakopoulou V, et al. Among authors: adjei aa. J Thorac Oncol. 2006 Sep;1(7):749-51. J Thorac Oncol. 2006. PMID: 17409953 Free article. Review.

3

Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer.

Adjei AA, Molina JR, Mandrekar SJ, Marks R, Reid JR, Croghan G, Hanson LJ, Jett JR, Xia C, Lathia C, Simantov R. Adjei AA, et al. Clin Cancer Res. 2007 May 1;13(9):2684-91. doi: 10.1158/1078-0432.CCR-06-2889. Clin Cancer Res. 2007. PMID: 17473200 Clinical Trial.

4

Small cell lung cancer.

Sher T, Dy GK, Adjei AA. Sher T, et al. Among authors: adjei aa. Mayo Clin Proc. 2008 Mar;83(3):355-67. doi: 10.4065/83.3.355. Mayo Clin Proc. 2008. PMID: 18316005 Review.

5

Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?

Langer CJ, Wakelee H, Schiller J, Choy H, Shepherd F, Vokes EE, Adjei AA, Baas P, Saijo N, Gandara DR. Langer CJ, et al. Among authors: adjei aa. Clin Lung Cancer. 2008 Mar;9(2):85-91. doi: 10.3816/CLC.2008.n.013. Clin Lung Cancer. 2008. PMID: 18501094 Review.

6

K-ras as a target for lung cancer therapy.

Adjei AA. Adjei AA. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S160-3. doi: 10.1097/JTO.0b013e318174dbf9. J Thorac Oncol. 2008. PMID: 18520303 Free article. Review.

7

Novel designs and end points for phase II clinical trials.

Adjei AA, Christian M, Ivy P. Adjei AA, et al. Clin Cancer Res. 2009 Mar 15;15(6):1866-72. doi: 10.1158/1078-0432.CCR-08-2035. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276272 Review.

8

Emerging therapeutic targets in non-small cell lung cancer.

Dy GK, Adjei AA. Dy GK, et al. Among authors: adjei aa. Proc Am Thorac Soc. 2009 Apr 15;6(2):218-23. doi: 10.1513/pats.200808-099LC. Proc Am Thorac Soc. 2009. PMID: 19349491 Review.

9

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

Adjei AA, Mandrekar SJ, Dy GK, Molina JR, Adjei AA, Gandara DR, Ziegler KL, Stella PJ, Rowland KM Jr, Schild SE, Zinner RG. Adjei AA, et al. J Clin Oncol. 2010 Feb 1;28(4):614-9. doi: 10.1200/JCO.2009.23.6406. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841321 Free PMC article. Clinical Trial.

10

Endpoints in phase II trials for advanced non-small cell lung cancer.

Mandrekar SJ, Qi Y, Hillman SL, Allen Ziegler KL, Reuter NF, Rowland KM Jr, Kuross SA, Marks RS, Schild SE, Adjei AA. Mandrekar SJ, et al. Among authors: adjei aa. J Thorac Oncol. 2010 Jan;5(1):3-9. doi: 10.1097/JTO.0b013e3181c0a313. J Thorac Oncol. 2010. PMID: 19884856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters